Expert analysis
Our analysts deliver cutting-edge insights on the trends shaping drug pipelines, competitive dynamics, and the evolving oncology treatment landscape, drawing directly from the data presented at ASCO 2026.
Why this matters
The annual meeting of the American Society of Clinical Oncology is where groundbreaking science, innovation, and connection come together to shape the future of cancer care.
But identifying the most relevant trends and updates amid all the noise can be challenging.
This post-conference report from GlobalData Healthcare distils the conference’s key insights through a GlobalData lens, highlighting major biopharmaceutical trends and notable developments across oncology to provide a clear perspective on the outlook for 2026.
GlobalData Healthcare Expert View
Deep proprietary insight
Exclusive analysis across pipelines, clinical trials, and deal activity, enriched by GlobalData datasets.
Analyst interpretation
Clear explanation of company strategies and their implications for the healthcare and oncology industry in 2026, designed for executive leadership, strategy, BD&L, and R&D teams.
Watch The Post-ASCO 2026 Webinar
Following the ASCO Annual Meeting, GlobalData Healthcare analysts are hosting a dedicated briefing to build on some of the most important strategic signals from ASCO 2026.
This webinar will explore cell therapy in oncology, building on findings from the post-conference report. Cutting through the noise at ASCO, our analysts have pulled out cell therapy as a key treatment area to tell you what’s changing, why it matters, and how you can adjust your strategy planning.
The webinar is taking place on 25 June at 3pm GMT.
Why GlobalData?
One unified intelligence platform
Proprietary data, expert analysis, and purpose-built AI connected in a single decision engine, giving you clarity on what’s coming and why it matters.
Depth and expertise you can trust
3,000 in-house subject matter experts and unrivalled datasets providing a complete, connected view of the healthcare landscape.
Built to accelerate action
AI-powered intelligence that reduces time from insight to decision, helping 5,000+ organizations move faster, de-risk choices, and lead with confidence.
ASCO 2026 Highlights Report
Register to receive a copy of the report featuring a comprehensive summary of the most important and practice-changing presentations from this year’s meeting.